CD8A and neoplasm: Recent studies suggest that a new mechanism plays an important role in complement signaling-mediated suppression of antitumor immunity: direct inhibition of IL-10 production in CD8+ tumor infiltrating lymphocytes (TILs) in TME (11, 14).